Trial
NCT01550705
Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria
UnknownTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University of Utah
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Icahn School of Medicine at Mount Sinai; University of Alabama at Birmingham; University of California, San Francisco; University of Texas
Condition
Erythropoietic Protoporphyria (EPP)
Intervention
Isoniazid
Why stopped
Interim analysis demonstrated the treatment was not effective
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-16